Corpus callosum index: A practical method for long-term follow-up in multiple sclerosis

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 4 A, 2007, Pages 931-935

  Figueira, Fernando Faria Andrade ^a   Dos Santos, Valeria Silva ^a   Figueira, Gustavo Medeiros Andrade ^b   Da Silva, Ângela Correa Marques ^a  

^a Dept of Neurology   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Corpus callosum; MRI; Multiple sclerosis

Indexed keywords

IMMUNOMODULATING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ATROPHY; CLINICAL EVALUATION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMOGRAPHY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPEN STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS;

EID: 37649005062     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2007000600001     Document Type: Article

References (17)

1. Lublin FD. Clinical features and diagnosis of multiple sclerosis. Neurol Clin 2005;23:1-15.
2. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7:115-121.
3. Prineas J. Pathology of multiple sclerosis. In Cook S (Ed.). Handbook of multiple sclerosis. Basel: Marcel Dekker, 2001:289-324.
4. Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 2001;14:271-278.
5. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of multiple sclerosis: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003;206:165-171.
6. Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001;185:19-26.
7. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698-1704.
8. Bakshi R, Dandamudi, VSR, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging 2005;15(Suppl):S30-S45.
9. Figueira F, Santos VS, Silva FC. A cognitive imaging correlate in multiple sclerosis. Rev Chil Neuropsiquiatr 2003;41:86-87.
10. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study. Brain 1989;112:799-835.
11. Hofer S, Frahma J. Topography of the human corpus callosum revisited. Comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage 2006;32:989-994.
12. Figueira F, Santos VS, Silva FC, Silva ACM. Corpus callosum index: a practical measure for long-term follow-up in multiple sclerosis. Neurology 2006;66:S10.006, A75.
13. McDonald WI, Compston A, Edan G, and the International Panel. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
14. Consortium of Multiple Sclerosis Centers. Available at http://www.mscare.org/. June 2003.
15. Figueira F, Santos VS, Silva FC, Silva ACM. Corpus callosum index: a prospective study on progressive MS. Arq Neuropsiquiatr 2006;64(Suppl):S164- P552.
16. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
17. Simon JH, Jacobs LD, Campion MK, and The Multiple Sclerosis Collaborative Research Group (MSCRG). A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology, 1999;53:139-148.